Carrier-mediated transport can obey fractal kinetics
- PMID: 7596989
- DOI: 10.1023/a:1016201929304
Carrier-mediated transport can obey fractal kinetics
Abstract
A model based on the fractal methodology is proposed for the kinetic study of carrier-mediated transport under heterogeneous conditions, i.e., when the drug-carrier interaction occurs at an interface with an effective dimensionality smaller than the embedding dimension of d = 2. A model equation is derived for the flux, based on a similar approach for an analogous equation for enzyme kinetics. It is shown that the total flux-solute concentration plots are curvilinear when the fractal dimension is smaller than unity while they become biexponential, with ascending and descending limbs, when the fractal dimension D is in the range 1 < D < 2. Nonlinear Lineweaver-Burk plots are obtained when this fractal kinetics approach is used. Good fittings are obtained when the fractal model is applied to literature data previously analysed with a combined transport mechanism, revealing experimental systems that display a D value in the range 1 < D < 2. It is suggested that transport studies should be carried out at a wider working solute concentration range and various agitation and incubation conditions in order to derive definite conclusions for the transport pathways.
Similar articles
-
Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.Pharm Res. 1998 Apr;15(4):620-5. doi: 10.1023/a:1011994230346. Pharm Res. 1998. PMID: 9587960
-
A fractal approach to heterogeneous drug distribution: calcium pharmacokinetics.Pharm Res. 1996 May;13(5):663-70. doi: 10.1023/a:1016031129053. Pharm Res. 1996. PMID: 8860420
-
A theoretical discussion of the use of the Lineweaver-Burk plot to estimate kinetic parameters of intestinal transport in the presence of unstirred water layers.Can J Physiol Pharmacol. 1981 Sep;59(9):932-48. doi: 10.1139/y81-144. Can J Physiol Pharmacol. 1981. PMID: 7296397
-
Evidence-based approach to assess passive diffusion and carrier-mediated drug transport.Drug Discov Today. 2012 Aug;17(15-16):905-12. doi: 10.1016/j.drudis.2012.03.015. Epub 2012 Apr 4. Drug Discov Today. 2012. PMID: 22507594 Review.
-
On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: a review.Int J Pharm. 2013 Nov 18;456(2):340-52. doi: 10.1016/j.ijpharm.2013.08.087. Epub 2013 Sep 8. Int J Pharm. 2013. PMID: 24025993 Review.
Cited by
-
Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.Pharm Res. 1998 Apr;15(4):620-5. doi: 10.1023/a:1011994230346. Pharm Res. 1998. PMID: 9587960
-
Fractal geometry, fractal kinetics and chaos en route to biopharmaceutical sciences.Eur J Drug Metab Pharmacokinet. 1996 Apr-Jun;21(2):77-86. doi: 10.1007/BF03190255. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8839680 Review. No abstract available.
-
A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac.J Pharmacokinet Pharmacodyn. 2010 Apr;37(2):119-34. doi: 10.1007/s10928-009-9147-3. Epub 2010 Jan 14. J Pharmacokinet Pharmacodyn. 2010. PMID: 20072802
-
Michaelis-Menten kinetics under spatially constrained conditions: application to mibefradil pharmacokinetics.Biophys J. 2004 Sep;87(3):1498-506. doi: 10.1529/biophysj.104.042143. Biophys J. 2004. PMID: 15345531 Free PMC article.
-
Comparison of the gamma-Pareto convolution with conventional methods of characterising metformin pharmacokinetics in dogs.J Pharmacokinet Pharmacodyn. 2020 Feb;47(1):19-45. doi: 10.1007/s10928-019-09666-z. Epub 2019 Dec 21. J Pharmacokinet Pharmacodyn. 2020. PMID: 31865474 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources